Court Urged To Reject Per Se Test In Challenges To Patent Settlements
In re Terazosin Hydrochloride Antitrust Litigation
This site uses cookies for performance, site traffic analysis, and social media purposes. Find out more about our cookie policy here. You can adjust your preferences in cookie settings.